Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 453

    1.

    Incidence of Appropriate Cardioverter-Defibrillator Shocks and Mortality in Patients With Heart Failure Treated With Combined Cardiac Resynchronization Plus Implantable Cardioverter-Defibrillator Therapy Versus Implantable Cardioverter-Defibrillator Thera.

    Desai H, Aronow WS, Ahn C, Tsai FS, Lai HM, Gandhi K, Amin H, Frishman WH, Kalapatapu K, Cohen M, Sorbera C.

    J Cardiovasc Pharmacol Ther. 2009 Dec 4. [Epub ahead of print]PMID: 19966176 [PubMed - as supplied by publisher]Related articles

    2.

    Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography.

    Cavusoglu E, Ruwende C, Chopra V, Poludasu S, Yanamadala S, Frishman WH, Eng C, Pinsky DJ, Marmur JD.

    Atherosclerosis. 2009 Nov 5. [Epub ahead of print]PMID: 19944421 [PubMed - as supplied by publisher]Related articles

    3.

    The emerging role of apelin in cardiovascular disease and health.

    Quazi R, Palaniswamy C, Frishman WH.

    Cardiol Rev. 2009 Nov-Dec;17(6):283-6.PMID: 19829178 [PubMed - in process]Related articles

    4.

    The patient-physician-industry-government partnership: a societal good.

    Frishman WH.

    Am J Med. 2009 Oct;122(10):886-7. No abstract available. PMID: 19786152 [PubMed - indexed for MEDLINE]Related articles

    5.

    Lipoprotein-associated phospholipase A2: an independent predictor of cardiovascular risk and a novel target for immunomodulation therapy.

    Khakpour H, Frishman WH.

    Cardiol Rev. 2009 Sep-Oct;17(5):222-9. Review.PMID: 19690473 [PubMed - indexed for MEDLINE]Related articles

    6.

    Prevalence of appropriate cardioverter-defibrillator shocks in 1038 consecutive patients with implantable cardioverter-defibrillators.

    Kruger A, Aronow WS, Lai H, Desai H, Singla A, Frishman WH, Cohen M, Sorbera C.

    Am J Ther. 2009 Jul-Aug;16(4):323-5.PMID: 19617719 [PubMed - indexed for MEDLINE]Related articles

    7.

    Statins reduce appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure and combined cardiac resynchronization and implantable cardioverter-defibrillator therapy.

    Desai H, Aronow WS, Tsai FS, Ahn C, Lai HM, Amin H, Gandhi K, Frishman WH, Cohen M, Sorbera C.

    J Cardiovasc Pharmacol Ther. 2009 Sep;14(3):176-9. Epub 2009 Jul 17.PMID: 19617418 [PubMed - indexed for MEDLINE]Related articles

    8.

    Endothelin as a clinical target in the treatment of systemic hypertension.

    Prasad VS, Palaniswamy C, Frishman WH.

    Cardiol Rev. 2009 Jul-Aug;17(4):181-91. Review.PMID: 19525680 [PubMed - indexed for MEDLINE]Related articles

    9.

    Cardiac manifestations of sarcoidosis and therapeutic options.

    Pierre-Louis B, Prasad A, Frishman WH.

    Cardiol Rev. 2009 Jul-Aug;17(4):153-8. Review.PMID: 19525676 [PubMed - indexed for MEDLINE]Related articles

    10.

    Smoking cessation pharmacotherapy.

    Frishman WH.

    Ther Adv Cardiovasc Dis. 2009 Aug;3(4):287-308. Epub 2009 Jun 2. Review.PMID: 19491139 [PubMed - indexed for MEDLINE]Related articles

    11.

    Adenosine1 receptor antagonism: a new therapeutic approach for the treatment of decompensated heart failure.

    Shah RH, Frishman WH.

    Cardiol Rev. 2009 May-Jun;17(3):125-31. Review.PMID: 19384086 [PubMed - indexed for MEDLINE]Related articles

    12.

    Targeting heme oxygenase: therapeutic implications for diseases of the cardiovascular system.

    Peterson SJ, Frishman WH, Abraham NG.

    Cardiol Rev. 2009 May-Jun;17(3):99-111. Review. Erratum in: Cardiol Rev. 2009 Jul-Aug;17(4):191. Abraham, Nader G [added]. PMID: 19384082 [PubMed - indexed for MEDLINE]Related articles

    13.

    Relation of baseline serum potassium levels to angiographic findings in patients with known or suspected coronary artery disease.

    Cavusoglu E, Chopra V, Gupta A, Choksi PU, Ruwende C, Yanamadala S, Frishman WH, Pinsky DJ, Marmur JD.

    Am J Hypertens. 2009 Jul;22(7):754-62. Epub 2009 Apr 16.PMID: 19373212 [PubMed - indexed for MEDLINE]Related articles

    15.

    Prevalence of Complications During Implantation and During 38-Month Follow-up of 1060 Consecutive Patients With Implantable Cardioverter-Defibrillators.

    Tsai FS, Aronow WS, Devabhaktuni S, Desai H, Kruger A, Lai HM, Frishman WH, Cohen M, Sorbera C.

    Am J Ther. 2009 May 19. [Epub ahead of print]PMID: 19262366 [PubMed - as supplied by publisher]Related articles

    16.

    Alternative and complementary medicine for preventing and treating cardiovascular disease.

    Frishman WH, Beravol P, Carosella C.

    Dis Mon. 2009 Mar;55(3):121-92. Review. No abstract available. PMID: 19215737 [PubMed - indexed for MEDLINE]Related articles

    17.

    beta-Adrenergic blockers: a 50-year historical perspective.

    Frishman WH.

    Am J Ther. 2008 Nov-Dec;15(6):565-76. Review.PMID: 19127141 [PubMed - indexed for MEDLINE]Related articles

    18.

    Updates on cytochrome P450-mediated cardiovascular drug interactions.

    Cheng JW, Frishman WH, Aronow WS.

    Am J Ther. 2009 Mar-Apr;16(2):155-63. Review.PMID: 19114873 [PubMed - indexed for MEDLINE]Related articles

    19.

    Fabry disease: cardiac manifestations and therapeutic options.

    Pierre-Louis B, Kumar A, Frishman WH.

    Cardiol Rev. 2009 Jan-Feb;17(1):31-5. Review.PMID: 19092368 [PubMed - indexed for MEDLINE]Related articles

    20.

    Cytokines and myocardial regeneration: a novel treatment option for acute myocardial infarction.

    Srinivas G, Anversa P, Frishman WH.

    Cardiol Rev. 2009 Jan-Feb;17(1):1-9. Review.PMID: 19092364 [PubMed - indexed for MEDLINE]Related articles

    21.

    Fifty years of beta-adrenergic blockade: a golden era in clinical medicine and molecular pharmacology.

    Frishman WH.

    Am J Med. 2008 Nov;121(11):933-4. No abstract available. PMID: 18954835 [PubMed - indexed for MEDLINE]Related articles

    22.

    Prasugrel: a new antiplatelet drug for the prevention and treatment of cardiovascular disease.

    Koo MH, Nawarskas JJ, Frishman WH.

    Cardiol Rev. 2008 Nov-Dec;16(6):314-8. Review.PMID: 18923235 [PubMed - indexed for MEDLINE]Related articles

    23.

    Vaccines in development to prevent and treat atherosclerotic disease.

    Riley E, Dasari V, Frishman WH, Sperber K.

    Cardiol Rev. 2008 Nov-Dec;16(6):288-300. Review.PMID: 18923232 [PubMed - indexed for MEDLINE]Related articles

    24.

    Device-based nonspecific immunomodulation therapy (Celacade), and its potential role in the treatment of chronic heart failure.

    Sporter RJ, Kim JH, Frishman WH.

    Cardiol Rev. 2008 Nov-Dec;16(6):280-7. Review. Erratum in: Cardiol Rev. 2009 Jan-Feb;17(1):43. PMID: 18923231 [PubMed - indexed for MEDLINE]Related articles

    25.

    Toll-like receptors: new therapeutic targets for the treatment of atherosclerosis, acute coronary syndromes, and myocardial failure.

    Erickson B, Sperber K, Frishman WH.

    Cardiol Rev. 2008 Nov-Dec;16(6):273-9. Review.PMID: 18923230 [PubMed - indexed for MEDLINE]Related articles

    26.

    Acute inferior wall myocardial infarction and percutaneous coronary intervention of the right coronary during active labor: a clinical report and review of the literature.

    Pierre-Louis B, Singh P, Frishman WH.

    Cardiol Rev. 2008 Sep-Oct;16(5):260-8. Review.PMID: 18708827 [PubMed - indexed for MEDLINE]Related articles

    27.

    Investigational antiplatelet drugs for the treatment and prevention of coronary artery disease.

    Zeidner JF, Frishman WH, Lerner RG.

    Cardiol Rev. 2008 Sep-Oct;16(5):250-9. Review.PMID: 18708826 [PubMed - indexed for MEDLINE]Related articles

    28.

    Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--Part II.

    Ahn A, Frishman WH, Gutwein A, Passeri J, Nelson M.

    Cardiol Rev. 2008 Sep-Oct;16(5):219-29. Review.PMID: 18708823 [PubMed - indexed for MEDLINE]Related articles

    29.

    Cholesteryl ester transfer protein inhibition for coronary heart disease prevention: real hope or despair?

    Frishman WH, Barkowski RS.

    Am J Med. 2008 Aug;121(8):644-6. No abstract available. PMID: 18691473 [PubMed - indexed for MEDLINE]Related articles

    30.

    U.S. medical students' perceptions of the adequacy of their schools' curricular attention to care at the end of life: 1998-2006.

    Sulmasy DP, Cimino JE, He MK, Frishman WH.

    J Palliat Med. 2008 Jun;11(5):707-16.PMID: 18588402 [PubMed - indexed for MEDLINE]Related articles

    31.

    Effect of beta blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and statins on mortality in patients with implantable cardioverter-defibrillators.

    Lai HM, Aronow WS, Kruger A, Desai H, Amin H, Frishman WH, Cohen M, Sorbera C.

    Am J Cardiol. 2008 Jul 1;102(1):77-8. Epub 2008 Apr 22.PMID: 18572039 [PubMed - indexed for MEDLINE]Related articles

    32.

    Statin-drug interactions: not a class effect.

    Frishman WH, Horn J.

    Cardiol Rev. 2008 Jul-Aug;16(4):205-12. Review.PMID: 18562811 [PubMed - indexed for MEDLINE]Related articles

    33.

    Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--part I.

    Ahn A, Frishman WH, Gutwein A, Passeri J, Nelson M.

    Cardiol Rev. 2008 Jul-Aug;16(4):163-71. Review.PMID: 18562806 [PubMed - indexed for MEDLINE]Related articles

    34.

    HDL metabolism and CETP inhibition.

    Barkowski RS, Frishman WH.

    Cardiol Rev. 2008 May-Jun;16(3):154-62.PMID: 18414186 [PubMed - indexed for MEDLINE]Related articles

    35.

    Urotensin II: a new pharmacologic target in the treatment of cardiovascular disease.

    Desai N, Sajjad J, Frishman WH.

    Cardiol Rev. 2008 May-Jun;16(3):142-53. Review.PMID: 18414185 [PubMed - indexed for MEDLINE]Related articles

    36.

    Flavanol-rich cocoa: a cardioprotective nutraceutical.

    Mehrinfar R, Frishman WH.

    Cardiol Rev. 2008 May-Jun;16(3):109-15. Review.PMID: 18414181 [PubMed - indexed for MEDLINE]Related articles

    37.

    Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertension.

    Huang J, Kaminski PM, Edwards JG, Yeh A, Wolin MS, Frishman WH, Gewitz MH, Mathew R.

    Am J Physiol Lung Cell Mol Physiol. 2008 Jun;294(6):L1250-9. Epub 2008 Apr 4.PMID: 18390833 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Cardiovascular and respiratory considerations with pharmacotherapy of glaucoma and ocular hypertension.

    Han JA, Frishman WH, Wu Sun S, Palmiero PM, Petrillo R.

    Cardiol Rev. 2008 Mar-Apr;16(2):95-108. Review.PMID: 18281912 [PubMed - indexed for MEDLINE]Related articles

    39.

    Cardiovascular considerations in patients undergoing gastrointestinal endoscopy.

    Ross C, Frishman WH, Peterson SJ, Lebovics E.

    Cardiol Rev. 2008 Mar-Apr;16(2):76-81. Review.PMID: 18281909 [PubMed - indexed for MEDLINE]Related articles

    40.

    Pharmacologic management of mesenteric occlusive disease.

    Frishman WH, Novak S, Brandt LJ, Spiegel A, Gutwein A, Kohi M, Rozenblit G.

    Cardiol Rev. 2008 Mar-Apr;16(2):59-68. Review.PMID: 18281907 [PubMed - indexed for MEDLINE]Related articles

    41.

    Myocardial regeneration and stem cell repair.

    Leri A, Kajstura J, Anversa P, Frishman WH.

    Curr Probl Cardiol. 2008 Mar;33(3):91-153. Review.PMID: 18243902 [PubMed - indexed for MEDLINE]Related articles

    42.

    Diagnosis and management of viral myocarditis.

    Frishman WH, Zeidner J, Naseer N.

    Curr Treat Options Cardiovasc Med. 2007 Dec;9(6):450-64.PMID: 18221597 [PubMed - in process]Related articles

    43.

    Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction.

    Frishman WH, Henderson LS, Lukas MA.

    Vasc Health Risk Manag. 2008;4(6):1387-400. Review.PMID: 19337551 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Pathophysiology, diagnosis, and treatment of orthostatic hypotension and vasovagal syncope.

    Medow MS, Stewart JM, Sanyal S, Mumtaz A, Sica D, Frishman WH.

    Cardiol Rev. 2008 Jan-Feb;16(1):4-20. Review.PMID: 18091397 [PubMed - indexed for MEDLINE]Related articles

    45.

    A tribute to Edmund H. Sonnenblick, MD: 1932-2007.

    Frishman WH.

    Cardiol Rev. 2008 Jan-Feb;16(1):1-3. No abstract available. PMID: 18091396 [PubMed - indexed for MEDLINE]Related articles

    46.

    Use of diuretics in the treatment of heart failure in the elderly.

    Sica DA, Gehr TW, Frishman WH.

    Heart Fail Clin. 2007 Oct;3(4):455-64.PMID: 17905380 [PubMed]Related articles

    47.

    Importance of medication adherence in cardiovascular disease and the value of once-daily treatment regimens.

    Frishman WH.

    Cardiol Rev. 2007 Sep-Oct;15(5):257-63. Review.PMID: 17700384 [PubMed - indexed for MEDLINE]Related articles

    48.

    Direct inhibition of renin as a cardiovascular pharmacotherapy: focus on aliskiren.

    Sepehrdad R, Frishman WH, Stier CT Jr, Sica DA.

    Cardiol Rev. 2007 Sep-Oct;15(5):242-56. Review.PMID: 17700383 [PubMed - indexed for MEDLINE]Related articles

    50.

    Humor and the cardiovascular system.

    Sahakian A, Frishman WH.

    Altern Ther Health Med. 2007 Jul-Aug;13(4):56-8. Review. No abstract available. PMID: 17658123 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...